Projected to surge from $380 million in 2022 to $6,091 million by 2035, the human microbiome market anticipates a robust CAGR of 23.8%. This growth trajectory is fueled by pipeline analysis, competitor insights, clinical trials, startups, partnerships, and detailed market analysis. Advancements since the Human Microbiome Project’s initiation in 2007 have illuminated the role of gut microbiota in health and disease pathogenesis, fostering increased investment and research in this field.

Know More